Parkinson’s Disease Therapeutics Market to Reach US$ 9.2 Bn by 2031, Driven by Innovation in Drug Development and Rising Patient Population
The global Parkinson’s disease therapeutics market size stood at US$ 5.1 Bn in 2022 and is expected to increase at a CAGR of 7.0% from 2023 to 2031, reaching US$ 9.2 Bn by the end of 2031. The market is experiencing steady growth due to the increasing prevalence of Parkinson’s disease, particularly among the aging population, and the continuous advancement in treatment options....
0 Commenti
0 condivisioni
96 Views